PREVIOUS
✖
TataMD CHECK
November 14 , 2020
1477 days
821
0
- Tata Medical and Diagnostics Ltd (TataMD) launched this new Diagnostic testing tool for covid-19.
- It is the world’s first CRISPR CaS-9 based diagnostic tool.
- It was developed in partnership with the Council of scientific and Industrial Research and Institute of genomics and integrative Biology.
- It is also powered by FELUDA.
Leave a Reply
Your Comment is awaiting moderation.